J9302 Ofatumumab injection
Also known as: ofatumumab, Arzerra
Injection of ofatumumab, an anti-CD20 monoclonal antibody. Human monoclonal antibody for chronic lymphocytic leukemia and follicular lymphoma.
In Plain Language
lymphoma injection; leukemia B-cell treatment
Clinical Context
Used for chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab. Provides alternative anti-CD20 targeting with direct cell lysis.
RVU Information
CPT J9302 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9302?
CPT J9302 (Ofatumumab injection) is a J Codes (Drugs) code. Injection of ofatumumab, an anti-CD20 monoclonal antibody. Human monoclonal antibody for chronic lymphocytic leukemia and follicular lymphoma.
How is J9302 administered?
CPT J9302 is administered by a healthcare provider, typically via injection or infusion. Used for chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab. Provides alternative anti-CD20 targeting with direct cell lysis. It is used by Oncology, Hematology, Internal Medicine.
When is CPT J9302 used?
Used for chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab. Provides alternative anti-CD20 targeting with direct cell lysis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.